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Obesity originates from a failure of the body-weight control systems, which may be affected
by changing environmental influences. Basically, the obesity risk depends on two important
mutually-interacting factors: (1) genetic variants (single-nucleotide polymorphisms, haplo-
types); (2) exposure to environmental risks (diet, physical activity etc.). Common single-
nucleotide polymorphisms at candidate genes for obesity may act as effect modifiers for
environmental factors. More than 127 candidate genes for obesity have been reported and there
is evidence to support the role of twenty-two genes in at least five different populations. Gene–
environment interactions imply that the synergy between genotype and environment deviates
from either the additive or multiplicative effect (the underlying model needs to be specified to
appraise the nature of the interaction). Unravelling the details of these interactions is a complex
task. Emphasis should be placed on the accuracy of the assessment methods for both genotype
and lifestyle factors. Appropriate study design (sample size) is crucial in avoiding false posi-
tives and ensuring that studies have enough power to detect significant interactions, the ideal
design being a nested case–control study within a cohort. A growing number of studies are
examining the influence of gene–environmental interactions on obesity in either epidemiolo-
gical observational or intervention studies. Positive evidence has been obtained for genes
involved in adiposity, lipid metabolism or energy regulation such as PPARg2 (Pro12Ala),
b-adrenoceptor 2 (Gln27Glu) or uncoupling proteins 1, 2 and 3. Variants on other genes
relating to appetite regulation such as melanocortin and leptin receptors have also been
investigated. Examples of some recently-identified interactions are discussed.
Obesity risk: Mutations: Physical activity: Diet: Gene–environment interaction
Genetics of obesity
Nowadays, the availability of genomics technology repre-
sents a major advance in the study of the genetics of
obesity(1,2). Human genetic differences appear at the level
of single-nucleotide polymorphisms, copy-number poly-
morphisms and the specific combinations of alleles
(haplotypes)(3,4). The configuration of multiple genes can
range from polygenic (i.e. many genes with a relatively
small contribution) to oligogenic (i.e. few genes with large
measurable effects often expressed on a residual polygenic
background). Indeed, it is this oligogenic architecture that
has justified the current efforts to map genes for complex
phenotypes. In the present paper the influence of a number
of single-nucleotide polymorphisms in genes encoding
factors regulating food and energy intake and factors
implicated in energy expenditure and adiposity will be
summarised.
Genes encoding factors regulating food and
energy intake
It is generally accepted that hypothalamic and brain stem
centres are involved in the regulation of food intake and
energy balance but only in the last decade has information
on the relevant regulatory factors and their genes become
available(5). Insulin was regarded as the only candidate for
the key role in body-weight regulation until the discovery
of leptin by Friedman and colleagues(6), one of the most
exciting findings of the last decade(7,8). This cytokine-like
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peptide, which is mainly expressed by adipocytes, is now
believed to be a key regulator of fat metabolism and
energy intake together with other adipokines(9).
Certain areas of the hypothalamus are rich in specific
receptors binding regulatory peptides and triggering central
regulatory mechanisms. Factors acting at the central
nervous system level include neuropeptide Y, cortico-
trophin-releasing hormone, pro-opiomelanocortin, a-
melanocyte-stimulating hormone, agouti-related protein,
melanin-concentrating hormone and cocaine- and amphe-
tamine-regulated transcript(10). Interactions between these
molecules involving complex neuronal mechanisms even-
tually influence behaviour and provide important links with
neuroendocrine regulation of other vital functions of the
organism(11).
Evidence is accumulating that most of the genes
encoding central peptide factors as well as their receptors
(leptin receptors, melanocortin receptors, neuropeptide Y
receptors) are polymorphic(12). Dominant inheritance of
obesity conferred by missense, nonsense and frameshift
mutations in the melanocortin 4 receptor (MC4R) gene has
been extensively reported in many populations, including
Spanish individuals(13,14). It has been estimated that 1–6%
of extremely-obese individuals harbour functionally-
relevant MC4R mutations(15). More than seventy mutations
of MC4R (fifty-seven non-synonymous, five nonsense and
ten frameshift mutations) have been reported, many of
them associated with dominant inheritance of obesity(14).
Functional studies showed that many of the missense
mutations also lead to a loss of function of MC4R(15).
Meanwhile, other mutations (i.e. Thr11Ser, Arg18Cys) and
two polymorphisms (Val103Ile, Ile251Leu) do not modify
the function of the MC4R in vitro(14).
A number of peptides synthesised along the gastro-
intestinal tract also affect food intake. They include ghrelin
(an orexigenic peptide mainly produced in the stomach),
cholecystokinin (produced in the small intestine and
acting as a short-term satiety signal) and peptide YY3–36
(produced in the colon and suppressing appetite for
£12 h)(16). Exploration of these signalling pathways
has started and it is becoming clear that polymorphism
in relevant genes may have important functional con-
sequences. For the ghrelin receptor gene two single-
nucleotide polymorphisms have been reported: Ala204Glu
and Phe279Leu, which selectively impair the constitutive
activity of the receptor in human subjects leading to short
stature and obesity that apparently develops during
puberty(17).
Genes encoding factors implicated in
energy expenditure
Adaptive thermogenesis in human subjects is closely re-
lated to the active mobilisation of lipids from fat tissues
and is of particular interest in relation to obesity(18).
Central neural pathways responsible for food-intake and
energy-expenditure regulation are closely interconnected.
The peripheral transmission of central commands to the fat
stores is mediated by the sympathetic nervous system. The
b-adrenoceptor (ADRB) gene family members (ADRB2,
ADRB3, ADRB1) are extensively-studied candidate genes
in the obesity field because of their participation in energy-
expenditure regulation(19).
The ADRB2 gene encodes a major lipolytic receptor
protein in human fat cells. Two common polymor-
phisms of the ADRB2 gene, characterised by an amino
acid replacement of arginine by glycine in codon 16
(Arg16Gly) and glutamine by glutamic acid in codon 27
(Gln27Glu) have been explored in several diseases, e.g.
hypertension and obesity(20–22). A relationship between
the Arg16Gly polymorphism and an altered function of
ADBR2 has been reported, leading to decreased agonist
sensitivity(23). Meanwhile, the Gln27Glu variant has also
been found to be linked to obesity in some populations. In
men the 27Glu allele has been associated with increased
BMI and subcutaneous fat and with elevated leptin and
TAG levels, while in women the 27Glu variant has been
reported to be linked to increased BMI, body fat mass and
waist:hip ratio(24).
The ADRB3 protein plays a role in adipocyte metabo-
lism, mediating the rate of lipolysis in response to
catecholamines, and ADRB3 agonists have potential anti-
diabetes and anti-obesity properties(19). A common poly-
morphism in this gene, characterised by an amino acid
replacement of tryptophan by arginine at position 64
(Trp64Arg), has been identified and may be linked to
lower lipolytic activity and may account for lipid accu-
mulation in the adipose tissue(25). A number of reports
have indicated a relationship between the Trp64Arg variant
of ADRB3 and obesity-related phenotypes(25). In relation to
BMI, more than nine studies had shown an association
between BMI and the Trp64Arg polymorphism in popu-
lations varying from 134 to 856 subjects(25). In addition,
two meta-analyses examining the effect of this mutation on
BMI have been published for Caucasian populations(25,26).
One of these meta-analyses included 2447 subjects and
the summary weighted mean difference in BMI was 0.30
(95% CI 0.13, 0.47) kg/m2, indicating that variant carriers
exhibited higher BMI (on the average, 0.30 kg/m2 higher)
than normal homozygous subjects(25). The second involved
7399 subjects but the results indicated no association(26).
The Trp64Arg polymorphism has been associated with
abdominal or visceral fat obesity in several populations
such as Caucasians and Japanese subjects(2). Similarly,
several studies carried out among Mexican American,
Japanese and Caucasians women have shown that carriers
of the Arg allele have a higher BMI and lower reduction in
visceral fat after weight loss(3). Interestingly, a gene–gene
interaction between the Trp64Arg variant of the ADRB3
gene and the Pro12Ala variant of the PPARg 2 gene has
been reported in Spanish and Mexican populations(27).
Whereas ADRB participate in the regulation of adaptive
thermogenesis as a component of sympathetic responses,
uncoupling proteins (UCP) are involved in the modulation
of heat-generating uncoupled respiration at the mitochon-
drial level(28). They represent a family of carrier proteins
localised in the inner layer of mitochondrial membranes.
There are different members: UCP 1 is mostly expressed
in brown adipose tissue and has a role in thermogenesis;
UCP2 is ubiquitously present in all tissues; UCP3 is
mainly expressed in skeletal muscle and brown adipose
tissue(29,30). Their putative role as ‘uncoupling proteins’
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has been intensively explored. Like UCP1, UCP2 mediates
mitochondrial proton leak, releasing energy stores as heat
and therefore affecting the efficiency of energy metab-
olism(31). The actual functions for UCP2 and UCP3 pro-
teins are still under investigation. It has been proposed that
UCP act as regulators of energy metabolism, being trans-
membrane fatty acid transporters in the mitochondria
facilitating proton exchange(32,33).
Moreover, a number of human studies have indicated a
relationship between UCP polymorphisms and exercise
efficiency, resting energy expenditure, substrate oxidation,
energy metabolism, BMI, obesity risk, type 2 diabetes risk,
leptin, fat accumulation, body-weight changes, physical
activity etc.(19). These observations have led to the con-
sideration of UCP2 and UCP3 as candidate genes for
obesity, given their function in the regulation of fuel
metabolism(34).
Several UCP2 gene variants have been described: a G/A
mutation in the promoter region –866G/A, a valine for
alanine substitution at amino acid 55 in exon 4 (Ala55Val)
and a 45 bp insertion/deletion in the untranslated region of
exon 8(33). The associations between these polymorphisms
of UCP2 and various aspects of obesity have been inten-
sively studied. From the literature, it seems that the G
allele in the promoter region of UCP2 increases obesity
risk, while affording relative protection for type 2 dia-
betes(33). On the other hand, the Ala55Val polymorphism
has been shown to be associated with increased exercise
efficiency(19). However, findings relating to the exon 8
insertion allele of the UCP2 gene have been inconsistent.
While no association with obesity has been observed in a
number of the studies conducted in several populations,
significant associations have been found between the exon
8 insertion of the UCP2 gene and BMI, fat mass and the
presence of obesity (ranging from P<0.01 to P<0.001)(19).
There are also several UCP3 gene variants. In linkage
studies some of the variants have been shown to be asso-
ciated with a higher obesity risk. Specifically, the –55C/T
polymorphism in the promoter region of this gene has been
shown to be associated with an elevated BMI, an increased
level of adiposity or a greater waist:hip ratio(19). However,
other authors have not found any relationship between this
polymorphism and a higher risk of obesity or changes
in metabolic rate(35). Some studies have even reported an
inverse correlation with BMI and the presence of the –55C/
T polymorphism(36).
As the UCP2–UCP3 gene cluster extends within a small
region of 40 kb of the genome, a haplotype study is a
useful tool to study its association with obesity. Using a
study sample comprising 193 obese children and adoles-
cents (cases) and 170 controls aged 6–18 years it has been
found that the individual polymorphisms are not associated
with obesity, but the (–866G; rs659 366)–(Del; 45 bp)–
(–55T; rs1 800 849) haplotype is significantly associated
with obesity and its presence in the control group increases
the insulin resistance risk by about nine times(4).
Genes encoding factors implicated in adipogenesis
The last group of genes acting in connection with peri-
pheral regulation of energy expenditure comprises the
transcription factors leading to adipogenesis and adipocyte
differentiation. The key factors are the PPARg , particularly
the adipose-specific isoform PPARg2(37,38). In a meta-
analysis examining the Pro12Ala polymorphism in 19 136
subjects a positive association with BMI has been found(3).
The frequency of the Ala allele, similar to other Caucasian
populations, has been found to be higher in obese subjects
(allelic frequency 0.13) than in controls (allelic frequency
0.08), suggesting that this polymorphism is associated with
obesity(19,39). There is also information on the functional
role of PPARg gene variants: some chimeric proteins
appear to have a reduced activity(40).
Gene–environment interactions in relation to
obesity phenotypes
Commonly, an obese individual will have inherited minor
functional mutations or gene variants in genes coding for
key proteins involved in the regulation of body weight(41).
These combined genetic effects account for the biological
diversity, and in their absence all organisms would respond
in a virtually identical manner to the same environmental
challenge. However, obesity development also depends on
family and lifestyle influences, as shown in Table 1(42).
Thus, the interaction between functional gene polymor-
phisms and environmental factors may play a substantial
role in the risk of developing obesity(43).
Research into gene–environment interactions suggests
that the interplay between genotype and environment
deviates from the additive or multiplicative effects of these
two factors (the underlying model needs to be specified to
appraise the nature of the interaction). This outcome could
be a result of chance alone, which highlights the impor-
tance of confirmatory findings, but an absence of inter-
action could also simply reflect the lack of statistical power
(i.e. sample size) of the study to detect such an effect(3).
Genotype–environment interactions arise when the re-
sponse of a phenotype (e.g. body weight) to environmental
changes (e.g. overfeeding) depends on the individual’s
genetic background. Most of the genetic epidemiology
studies on human obesity have assumed the absence of
genotype–environment interactions simply because of the
difficulties in assessing such interactive effects in quanti-
tative genetic models(3).
There are several plausible scenarios for the interaction
between genetic and environmental factors. A higher
obesity risk (represented by a quantitative trait BMI) will
Table 1. Multivariate conditional logistic regression model of risk
factors for childhood obesity (modified from Ochoa et al.(42))
OR 95% CI P
Family obesity 4.46 2.21, 9.00 <0.01
Physical activity (for each
MET-hour per week)
0.94 0.92, 0.96 <0.01
TV watching (for each
hour per week)
1.07 1.00, 1.14 0.03
Soft drinks (for each
additional serving per d)
1.49 1.07, 2.06 0.02
MET, energy expended during each specific activity: RMR; TV, television.
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arise from the presence of obesity-related gene variants
and environmental influences (i.e. high consumption of
carbohydrates (CHO), low levels of physical activity) for
a population carrying a given polymorphism. Indeed,
individuals inherit a number of gene variants in key loci,
but they also make specific lifestyle choices (e.g. low-fat
v. high-fat diets, high v. low levels of physical activity etc.)
that affect weight gain. Thus, while environmental factors
may be changed in the short term, genetic factors cannot,
but they might interplay.
The gene–environment relationship is a key issue not
only in understanding the pathogenesis of multifactorial
diseases, but also in designing appropriate treatments
(i.e. ‘personalised nutrition’). It is possible to investigate
gene–lifestyle interactions in human obesity using either
intervention or epidemiological observational studies
relating to the influence of the whole genome or specific
gene variants. The remainder of the paper will review
some examples of gene–lifestyle interactions relating to the
diet and physical activity of obese subjects.
Gene variants, carbohydrate consumption and
obesity risk
Few attempts have been made to examine the influence
of gene–diet interactions on obesity-related phenotypes.
A case–control design with selected criteria for inclusion
(BMI >30 kg/m2 for cases and BMI <25 kg/m2 for con-
trols) has found a significant interaction between obesity
risk and high levels of CHO consumption (>49% total
energy) for carriers of the Glu allele of the ADRB2
gene(44). Obesity incidence was not found to be directly
affected by the polymorphism (OR 1.40, P=0.246), but
using a multivariate logistic model after adjustment for
confounding factors and/or effect modifiers a marginally-
significant interaction between the single-nucleotide
polymorphism and CHO intake was found among women.
This finding suggests that a dietary intake higher than the
median CHO consumption (>49% total energy) produces
an increased obesity risk in those women carrying the
Glu27 allele (OR 2.56, P=0.051) when adjusted for age
and physical activity. A second model, using CHO:fat
instead of the percentage energy derived from CHO, sup-
ports these results; a CHO intake:fat intake of >1.77 was
found to be associated with a higher risk of obesity
(OR 3.21, P<0.02) in women with the ADRB2 gene
polymorphism. The natural logarithms of the OR of being
obese for women with and without the polymorphism
according to the intake of CHO were found to be margin-
ally significant for women with the polymorphism
(b 0.074, P=0.056), using the lower level of intake as the
reference and adjusting for age and physical activity
(Fig. 1). Among female subjects bearing the Glu27 poly-
morphism an association between high CHO intake and
higher insulin levels (P<0.03) was found, which may
contribute to the greater likelihood of an onset of obesity
among these subjects. The fact that some studies have
shown that a polymorphism on the ADRB2 gene adversely
reduces fat oxidation(45), which may consequently be
associated with hyperlipidaemia, insulin resistance and
hyperinsulinaemia, also helps to explain that carriers of
the Glu27 allele may show an impaired response after
high CHO intake, leading to obesity.
Interestingly, a series of research papers has been
devoted to the interplay between the polymorphism
Pro12Ala of the PPARg 2 gene and dietary patterns in
relation to obesity phenotypes(3). In vivo ligands for
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Fig. 1. Obesity risk linked to the single-nucleotide polymorphism
Gln27Glu of the b-adrenoceptor 2 gene depends on carbohydrate
(CHO) consumption. Natural logarithms of the OR (LnOR) of being
obese for women with (K) and without (m) the polymorphism
(logistic regression model) according to the intake of CHO (%
energy) and adjusting for age and physical activity during leisure
time (metabolic equivalent-hours/week). For interaction, P=0.056.
(From Martı´nez et al.(44).)
Table 2. Obesity risk linked to the Pro12Ala polymorphism of the
PPARg 2 gene depends on carbohydrate (CHO) consumption
(from Marti et al.(39))
Crude
OR P
Adjusted
OR P
Low CHO
(<49% total energy)
0.50 0.19 0.46 0.2
High CHO
(>49% total energy)
4.78 0.045 5.12 0.05
Table 3. Obesity risk linked to the single-nucleotide polymorphism
Trp64Arg of the b-adrenoceptor 3 (ADRB3) gene depends on
physical activity (PA) levels (from Marti et al.(49))
Trp64 Arg64
Cases:control
Low PA (M/S<0.5) 1.84 5.5
High PA (M/S>0.5) 0.23 0.20
OR
Low PA 1.(reference)* 2.98*
High PA 0.13* 0.11*
For interaction recreational activity · ADRB3 mutation, P = 0.06.
M/S, metabolic equivalent-hours per week: time spent sitting down during
leisure time.
*0.13 !· 7 1 (reference) !· 3 2.98  · 27 0.11:
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PPARg2 are thought to include a variety of fatty acids
according to their chain length or extent of saturation. An
inverse interaction between dietary polyunsaturated fat:
saturated fat and BMI among 12Ala carriers was found, the
mean BMI being greater in Ala carriers than in Pro/Pro
homozygotes when polyunsaturated fat:saturated fat is low.
In a population of women of larger body size the intake of
saturated fat was found to be directly associated with
increased BMI in carriers and non-carriers of the 12Ala
variant, whereas the intake of monounsaturated fat was
shown to be inversely associated with BMI only in 12Ala
carriers of the PPARg2 polymorphism(46).
A case–control study has reported a higher risk of obe-
sity for carriers of the 12Ala variant with increasing intake
of arachidonic acid(47), whereas the author’s group has
found an increased obesity risk for carriers of the 12Ala
allele when consuming >49% total energy from CHO
(Table 2)(39).
Gene variants, physical activity levels and obesity risk
To estimate physical activity levels face-to-face interviews
were conducted with volunteers and validated question-
naires relating to their participation (number of hours per
week) in different sports, exercises or physical activities
(using the compendium of physical activities(48)) were
completed. The amount and intensity of leisure time were
quantified by assigning metabolic equivalents (energy
expended during each specific activity:RMR) to each
activity(42,49).
In a case–control study that assessed the role of the
Trp64Arg mutation of the ADRB3 gene on the risk of
developing obesity it was found that the effect of the
ADRB3 mutation on obesity risk changes depending on
the recreational physical activity levels(49). The metabolic
equivalent-hours/week:time spent sitting down during
leisure time (M/S) was used to estimate recreational energy
expenditure. An effect modification across recreational
physical activity strata was apparent, and a univariate
OR of 2.98 (95% CI 1.00, 8.56) was found within the
sedentary group (low physical activity; M/S<0.5) whereas
no increment in risk was apparent for active subjects
(high physical activity; M/S>0.5). When the association
between the risk of obesity and the Trp64Arg mutation
was adjusted for gender and age using multivariate
logistic regression models and introducing a product-term
(age · ADRB3 mutation), a borderline significant inter-
action (P=0.06) between recreational activity and the
ADRB3 mutation was demonstrated (Table 3). Thus,
carriers of the Trp64Arg mutation with low levels of
Coefficients  P
M/S 0·41
SE
Age (years) 0·01
Glu27 allele 0·39
Product term (M/S × Glu27 allele )
–1·52
0·04
–0·88
1·28 0·45
<0·001
0·007
0·024
0·005
20
22
24
26
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30
32
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36
M/S <0·9 M/S >0·9
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Fig. 2. Obesity risk linked to the single-nucleotide polymorphism Gln27Glu of the b-adrenoceptor 2 gene depends on physical activity levels.
(A) The change in the magnitude of the association between the Gln27 allele (*, Gln27;&, Glu27) and the obesity risk is dependent on the
exposure to physical activity (metabolic equivalent-hours per week:time spent sitting down during leisure time; M/S). (B) Average BMI for
subjects with (///) and without (K) the Glu27 polymorphism. Values are means with their standard errors represented by vertical bars. The
table shows coefficients obtained with the multivariate logistic regression model using obesity (BMI>30 kg/m2) as the outcome and represent
the independent effects for recreational energy expenditure (M/S), age and the Glu27 polymorphism and a product term assessing the effect
modification of the polymorphism by M/S. (From Corbala´n et al.(50).)
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physical activity have the highest risk of obesity after
adjustment for age and gender.
The association between the 27Glu polymorphism and
obesity risk has been estimated using multivariate logistic
regression(50). An effect modification (interaction) on the
risk of obesity linked to the 27Glu polymorphism by the
level of recreational energy expenditure (M/S) was derived
after adjustment for age. A significant interaction (product
term M/S · 27Glu allele; P=0.005) between recreational
energy expenditure and the 27Glu allele was demonstrated
(Fig. 2). The mean BMI of the two groups was compared
on the basis of energy expenditure using the 75th per-
centile of energy expenditure during leisure time as a
cut-off (M/S 0.9). Interestingly, a significant interaction
was found in the linear model between the Glu27 allele
and the M/S (P=0.003). Women who were more active
in their leisure time (M/S>0.9) and were carriers of the
27Glu allele had a higher BMI compared with non-carriers.
The data demonstrate that obese women who are carriers
of the 27Glu allele do not benefit equally from physical
activity compared with non-carriers. Such individuals may
be more resistant to losing weight when they participate in
higher physical activity levels.
Physical activity in children and adolescents seems
to be declining, while their time spent in sedentary ac-
tivities such as television (TV) watching is increasing.
Time spent watching TV replaces more vigorous activities
and increases the likelihood of children adopting unhealthy
food habits, thus it is a risk factor for obesity. This
change in activity may explain why TV viewing is a
significant predictor of BMI and overweight in childhood
and has been validated as a good index of sedentary
behaviour.
A matched case–control study was conducted to assess
the interaction between the Gln27Glu polymorphism of
the ADRB2 and TV viewing (as a proxy for sedentary
lifestyles) in relation to obesity in a group of Spanish
children and adolescents(51). The study population com-
prised 330 Spanish children and adolescents. Cases (n 165)
were subjects aged 5–18 years with a BMI of >97th per-
centile of the Spanish BMI reference data for age and
gender(52). Using logistic regression analysis it was found
that the Glu27Glu genotype of the ADRB2 gene was not
associated with obesity in boys in the fully-adjusted model.
However, female subjects carriers of the 27Glu allele
(twenty-five homozygous Glu27Glu and ninety-three hetero-
zygous: Glu27Gln) were found to have a significantly
higher risk of obesity (OR 1.95 (95% CI 1.02, 3.70)) in the
completely-adjusted model. When the OR for obesity for
girls were calculated for the presence of the 27Glu allele
in homozygotes, the values were higher (OR 2.83 (95% CI
1.12, 7.19). In the fully-adjusted model when physical
activity (metabolic equivalent-hours per week) and the
usual time spent in watching TV were also taken into
account and introduced in the model the adjusted OR for
obesity linked to the genotype Glu27Glu in the female
population rose to 4.84 (95% CI 1.37, 17.10).
An effect modification (interaction) on obesity risk
linked to the Gln27Glu polymorphism of the ADRB2 gene
by the number of hours spent watching TV (P=0.023) was
Girls OR 95 % CI P
Gln27Glu genotype 7·92 1·89, 33·2 0·005
Physical activity (MET-hours per week) 0·92 0·88, 0·96 <0·001
TV watching (h/week) 1·14 1·05, 1·24 0·003
Interaction term (product  Gln27Glu × 0·92 0·85, 0·99 0·023
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Fig. 3. Obesity risk linked to the single-nucleotide polymorphism Gln27Glu of the
b-adrenoceptor 2 gene depends on the time spent watching television (TV) in Spanish
children and adolescents aged 5–18 years with a BMI of >97th percentile of the Spanish
BMI reference data for age and gender(52). MET, energy expended during each specific
activity: RMR; (m), Carriers; (*), non-carriers. (From Ochoa et al.(51).)
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observed after adjustment for physical activity (Fig. 3). In
order to calculate different OR for sedentary and non-
sedentary subjects the female population was subdivided
using the median of the number of hours spent watching
TV (12.5 h/week). In homozygous subjects for the wild-
type genotype the risk of obesity was found to increase
seven times for sedentary girls (i.e. they spent >12.5 h/
week watching TV; OR 7.27 (95% CI 1.42, 37.13)) as
compared with non-sedentary girls (<12.5 h/week watch-
ing TV). Surprisingly, among subjects who were 27Glu
carriers even girls with a low level of TV watching
(<12.5 h/week) were found to have a high obesity risk (OR
4.60 (95% CI 1.01, 20.02)), which was not very different
from the OR values for sedentary girls (>12.5 h/week
watching TV; OR 6.05 (95% CI 1.31, 27.71)). These
results suggest that carriers of the 27Glu allele of the
ADRB2 gene may not benefit from a reduction in sedentary
behaviour as much as the subjects who do not carry the
polymorphism.
Conclusion
There is now evidence to indicate that most of the sus-
ceptibility genes for obesity do not have a main aetiologi-
cal role, but it is likely that they act as effect modifiers to
environmental factors such as diet or physical activity.
This finding implies that lifestyle factors should be inves-
tigated in genetics studies and that genetic factors should
be determined in dietary interventions and in clinical
trials. Thus, it is crucial to take into consideration gene–
environmental interactions when designing programmes
for both obesity prevention and treatment.
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